 MENLO PARK, Calif., May 21, 2021 GLOBE NEWSWIRE -- Pacific Biosciences of California, Inc. NASDAQ: PACB Pacific Biosciences or the Company, a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Companys Board of Directors granted non-qualified stock options covering an aggregate of 240,000 shares of Pacific Biosciences common stock and restricted stock units RSUs covering 130,000 shares of Pacific Biosciences common stock to two recently hired employees under the Pacific Biosciences 2020 Inducement Equity Incentive Plan the 2020 Inducement Plan effective on May 17, 2021. 